• Global Innovative Platforms seated its board effective April 1, 2026, naming David M. Mauer, Anthony (Tony) Porter, James (Jim) Jones, Dr. Elyssa J. Campbell.
• Mauer previously led Mattel U.S.A. as president, ran Riddell Sports as CEO; Porter brings 30+ years in healthcare commercialization, M&A, corporate development.
• Jones is a registered professional engineer, licensed attorney with board and governance experience; Campbell is a University of Georgia parasitologist, NIH resource center director.
• Dr. Sarah Cutler Tew joined as lead clinical development and scientific advisor via SC2 Consulting; previously held senior roles at Merial, Boehringer Ingelheim, IDEXX, PetIQ.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Innovative Platforms Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001376474-26-000442), on June 15, 2026, and is solely responsible for the information contained therein.